Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis

Journal of Pathology

Volumn 235, Issue 2, 2015, Pages 266-276

  Pickles, Raymond J ^a   DeVincenzo, John P ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Acute lung disease; Airway obstruction; Bronchiolitis; Respiratory syncytial virus

Indexed keywords

ARTICLE; BRONCHIOLE; BRONCHUS OBSTRUCTION; CYTOPATHOLOGY; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; INFLAMMATION; NONHUMAN; RESPIRATORY AIRFLOW; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY VIRUS; VIRAL BRONCHIOLITIS; VIRUS PATHOGENESIS; WHEEZING; ANIMAL; BIOPSY; BRONCHIOLITIS; DISEASE MODEL; HOST PATHOGEN INTERACTION; HUMAN RESPIRATORY SYNCYTIAL VIRUS; MOLECULAR PATHOLOGY; PATHOGENICITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VIROLOGY; VIRULENCE;

ANIMALS; BIOPSY; BRONCHIOLES; BRONCHIOLITIS; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMANS; PATHOLOGY, MOLECULAR; PREDICTIVE VALUE OF TESTS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VIROLOGY; VIRULENCE;

EID: 84917710717     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4462     Document Type: Article

References (73)

1. Wright AL, Taussig LM, Ray CG, et al. The Tucson Children's Respiratory Study. II. Lower respiratory tract illness in the frst year of life. Am J Epidemiol 1989; 129: 1232-1246.
2. Edwards KM, Zhu Y, Griffn MR, et al. Burden of human metapneu-movirus infection in young children. N Engl J Med 368: 633-643.
3. Glezen WP, Taber LH, Frank AL, et al. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140: 543-546.
4. Hall CB. Respiratory syncytial virus and parainfuenza virus. N Engl J Med 2001; 344: 1917-1928.
5. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360: 588-598.
6. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375: 1545-1555.
7. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. J Am Med Assoc 1999; 282: 1440-1446.
8. Shay DK, Holman RC, Roosevelt GE, et al. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis 2001; 183: 16-22.
9. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with infuenza and respiratory syncytial virus in the United States. J Am Med Assoc 2003; 289: 179-186.
10. Hislop AA, Haworth SG. Airway size and structure in the normal fetal and infant lung and the effect of premature delivery and artifcial ventilation. Am Rev Respir Dis 1989; 140: 1717-1726.
11. Aherne W, Bird T, Court S, et al. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970; 23: 7-18.
12. Garcia CG, Bhore R, Soriano-Fallas A, et al. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 126: e1453-1460.
13. Hervas D, Reina J, Yanez A, et al. Epidemiology of hospitaliza-tion for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis. Eur J Clin Microbiol Infect Dis 31: 1975-1981.
14. Bourgeois FT, Valim C, McAdam AJ, et al. Relative impact of infuenza and respiratory syncytial virus in young children.Pediatrics 2009; 124: e1072-1080.
15. Collins PL, Chanock RM, Murphy BR. Respiratory syncytial virus. In Field's Virology, 4th edn, Knipe DM and Howley PM (eds.). Lippincott Williams and Wilkins: Philadelphia, 2001; 1443-1485.
16. Monto AS, Malosh RE, Petrie JG, et al. Frequency of acute respiratory illnesses and circulation of respiratory viruses in households with children over 3 surveillance seasons. J Infect Dis 2014; 210: 1792-1799.
17. Chanock RM, Finberg L. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA) II. Epidermological aspect s of infection in infants and young children. Am J Hyg 1957; 66: 291-300.
18. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study, 2010. Lancet 380: 2095-2128.
19. Hon KL, Leung TF, Cheng WY, et al. Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis. J Crit Care 27: 464-468.
20. Stang P, Brandenburg N, Carter B. The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations. Arch Pediatr Adolesc Med 2001; 155: 95-96.
21. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 143: S127-132.
22. Leader S, Kohlhase K. Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J 2002; 21: 629-632.
23. Miller WT, Jr., Barbosa E, Jr., Mickus TJ, et al. Chest computed tomographic imaging characteristics of viral acute lower respiratory tract illnesses: a case-control study. J Comput Assist Tomogr 35: 524-530.
24. Miller WT Jr, Mickus TJ, Barbosa E Jr, et al. CT of viral lower respiratory tract infections in adults: comparison among viral organisms and between viral and bacterial infections. Am J Roentgenol 197: 1088-1095.
25. Shedden WI, Emery JL. Immunofuorescent evidence of respiratory syncytial virus infection in cases of giant cell bronchiolitis in children. J Pathol Bacteriol 1965; 89: 343-347.
26. Zinserling A. Pecularities of lesions in viral and mycoplasma infections of the respiratory tract. Virchows Arch A Pathol Pathol Anat 1972; 356: 259-273.
27. Johnson JE, Gonzales RA, Olson SJ, et al. The histopathologyof fatal untreated human respiratory syncytial virus infection. Mod Pathol 2007; 20: 108-119.
28. Welliver TP, Reed JL, Welliver RC, Sr. Respiratory syncytial virus and infuenza virus infections: observations from tissues of fatal infant cases. Pediatr Infect Dis J 2008; 27: S92-96.
29. Welliver TP, Garofalo RP, Hosakote Y, et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and infuenza virus is characterized by the absence of pulmonary cyto-toxic lymphocyte responses. J Infect Dis 2007; 195: 1126-1136.
30. Neilson KA, Yunis EJ. Demonstration of respiratory syncytial virus in an autopsy series. Pediatr Pathol 1990; 10: 491-502.
31. Smith PK, Wang SZ, Dowling KD, et al. Leucocyte populations in respiratory syncytial virus-induced bronchiolitis. J Paediatr Child Health 2001; 37: 146-151.
32. McNamara PS, Ritson P, Selby A, et al. Bronchoalveolar lavage cel-lularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child 2003; 88: 922-926.
33. McNamara PS, Flanagan BF, Baldwin LM, et al. Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet 2004; 363: 1031-1037.
34. McNamara PS, Flanagan BF, Selby AM, et al. Pro-and anti-infammatory responses in respiratory syncytial virus bronchi-olitis. Eur Respir J 2004; 23: 106-112.
35. McNamara PS, Smyth RL. The pathogenesis of respiratory syncytial virus disease in childhood. Br Med Bull 2002; 61: 13-28.
36. DeVincenzo JP, Wilkinson T, Vaishnaw A, et al. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am J Respir Crit Care Med 182: 1305-1314.
37. Buckingham SC, Bush AJ, Devincenzo JP. Nasal quantity of respiratory syncytical virus correlates with disease severity in hospitalized infants. Pediatr Infect Dis J 2000; 19: 113-117.
38. Everard ML, Swarbrick A, Wrightham M, et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994; 71: 428-432.
39. DeVincenzo JP, Whitley RJ, Mackman RL, et al. Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med 371: 711-722.
40. Olivier A, Gallup J, de Macedo MM, et al. Human respiratory syncy-tial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs. Int J Exp Pathol 2009; 90: 431-438.
41. Olivier AK, Gallup JM, van Geelen A, et al. Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses. Exp Lung Res 37: 131-143.
42. Derscheid RJ, Ackermann MR. Perinatal lamb model of respiratory syncytial virus (RSV) infection. Viruses 4: 2359-2378.
43. Sow FB, Gallup JM, Krishnan S, et al. Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-infammatory response in the lungs of preterm lambs. Respir Res 12: 106.
44. Bryson DG, McConnell S, McAliskey M, et al. Ultrastructural features of alveolar lesions in induced respiratory syncytial virus pneumonia of calves. Vet Pathol 1991; 28: 286-292.
45. Bryson DG, Platten MF, McConnell S, et al. Ultrastructural features of lesions in bronchiolar epithelium in induced respiratory syncytial virus pneumonia of calves. Vet Pathol 1991; 28: 293-299.
46. Valarcher JF, Taylor G. Bovine respiratory syncytial virus infection. Ve t R e s 2007; 38: 153-180.
47. Philippou S, Otto P, Reinhold P, et al. Respiratory syncytial virus-induced chronic bronchiolitis in experimentally infected calves. Virchows Arch 2000; 436: 617-621.
48. Viuff B, Tjornehoj K, Larsen LE, et al. Replication and clearance of respiratory syncytial virus: apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus. Am J Pathol 2002; 161: 2195-2207.
49. Papin JF, Wolf RF, Kosanke SD, et al. Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants. Am J Physiol Lung Cell Mol Physiol 304: L530-539.
50. Moore ML, Chi MH, Luongo C, et al. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol 2009; 83: 4185-4194.
51. Stokes KL, Chi MH, Sakamoto K, et al. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J Virol 85: 5782-5793.
52. Moore ML, Peebles RS Jr. Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Pharmacol Ther 2006; 112: 405-424.
53. Bem RA, Domachowske JB, Rosenberg HF. Animal models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol 301: L148-156.
54. Zhang L, Peeples ME, Boucher RC, et al. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specifc to ciliated cells, and without obvious cytopathology. J Virol 2002; 76: 5654-5666.
55. Zhang L, Bukreyev A, Thompson CI, et al. Infection of ciliated cells by human parainfuenza virus type 3 in an in vitro model of human airway epithelium. J Virol 2005; 79: 1113-1124.
56. Zhang L, Button B, Gabriel SE, et al. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fbrosis airway epithelium. PLoS Biol 2009; 7: e1000155.
57. Villenave R, Thavagnanam S, Sarlang S, et al. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc Natl Acad Sci USA 109: 5040-5045.
58. Sims AC, Baric RS, Yount B, et al. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Vi ro l 2005; 79: 15511-15524.
59. Pyrc K, Sims AC, Dijkman R, et al. Culturing the unculturable: human coronavirus HKU1 infects, replicates, and produces progeny virions in human ciliated airway epithelial cell cultures. J Virol 84: 11255-11263.
60. Fulcher ML, Gabriel S, Burns KA, et al. Well-differentiated human airway epithelial cell cultures. Methods Mol Med 2005; 107: 183-206.
61. Villenave R, O'Donoghue D, Thavagnanam S, et al. Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells. Vi ro l J 8: 43.
62. Zhang L, Collins PL, Lamb RA, et al. Comparison of differing cytopathic effects in human airway epithelium of parainfuenza virus 5 (W3A), parainfuenza virus type 3, and respiratory syncytial virus. Virology 421: 67-77.
63. Villenave R, Touzelet O, Thavagnanam S, et al. Cytopathogenesis of Sendai virus in well-differentiated primary pediatric bronchial epithelial cells. J Virol 84: 11718-11728.
64. Scull MA, Gillim-Ross L, Santos C, et al. Avian infuenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways. PLoS Pa t h o g 2009; 5: e1000424.
65. Thompson CI, Barclay WS, Zambon MC, et al. Infection of human airway epithelium by human and avian strains of infuenza a virus. J Virol 2006; 80: 8060-8068.
66. Matrosovich MN, Matrosovich TY, Gray T, et al. Human and avian infuenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA 2004; 101: 4620-4624.
67. Bartlett EJ, Hennessey M, Skiadopoulos MH, et al. Role of interferon in the replication of human parainfuenza virus type 1 wild type and mutant viruses in human ciliated airway epithelium. J Virol 2008; 82: 8059-8070.
68. Schaap-Nutt A, Liesman R, Bartlett EJ, et al. Human parainfuenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium. Virology 433: 320-328.
69. Smith CM, Fadaee-Shohada MJ, Sawhney R, et al. Ciliated cultures from patients with primary ciliary dyskinesia do not produce nitric oxide or inducible nitric oxide synthase during early infection. Chest 144: 1671-1676.
70. Mata M, Martinez I, Melero JA, et al. Rofumilast inhibits respiratory syncytial virus infection in human differentiated bronchial epithelial cells. PLoS One 8: e69670.
71. Liesman RM, Buchholz UJ, Luongo CL, et al. RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction. J Clin Invest 124: 2219-2233.
72. Wong JY, Rutman A, O'Callaghan C. Recovery of the ciliated epithelium following acute bronchiolitis in infancy. Thorax 2005; 60: 582-587.
73. Randell SH, Boucher RC. Effective mucus clearance is essential for respiratory health. Am J Respir Cell Mol Biol 2006; 35: 20-28.